Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems-Reference-Cited by-同舟云学术

Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems

Published:2003-08 Issue:4 Volume:35 Page:418-427
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Santamaría Abel,Flores-Escartín Abigail,Martínez Juan Carlos,Osorio Laura,Galván-Arzate Sonia,Chaverrí José Pedraza,Maldonado Perla D,Medina-Campos Omar N,Jiménez-Capdeville María E,Manjarrez Joaquín,Ríos Camilo

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference59 articles.

1. Copper biochemistry and molecular biology;Linder;Am. J. Clin. Nutr,1996

2. Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants;Gutteridge;Biochim. Biophys. Acta,1983

3. The effects of copper ions on glutamate receptors in cultured rat cortical neurons;Weiser;Brain Res,1996

4. Deficiency of copper can cause neuronal degeneration;Hartmann;Med. Hypotheses,1992

5. Distribution of metal ions in the subcellular fractions of several rat brain areas;Rajan;Life Sci,1976

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory mechanisms of copperII-albumin complex toward N-nitrosodiethylamine-induced neurotoxicity in mice via regulating oxidative damage, inflammatory, and apoptotic signaling pathways;Ecotoxicology and Environmental Safety;2024-01

2. Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications;Anhedonia: Preclinical, Translational, and Clinical Integration;2022

3. YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes;NeuroToxicology;2021-12

4. Cytotoxicity models of Huntington’s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies;Pharmacological Research;2019-12

5. Translational Medicine Strategies in Drug Development for Mood Disorders;Translational Medicine in CNS Drug Development;2019